EFDID: 71471EFD: View Filing

Issuer: Cynapsus Therapeutics Inc. (0001532079) - D

Accession: 0001532079-13-000002 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
  • Entity Name:
    Cynapsus Therapeutics Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    ONTARIO, CANADA
  • Year of Inc:
    Over 5 years ago
  • Address:
    828 RICHMOND STREET WEST
    TORONTO, A6 M6J 1C9
  • Persons:
    Related Persons 9
    Anthony Giovinazzo
    Executive OfficerDirector
    Andrew Williams
    Executive Officer
    Nathan Bryson
    Executive Officer
    Perry Molinoff
    Director
    Julia Levy
    Director
    Ronald Hosking
    Director
    Alan D. C. Ryley
    Director
    Rochelle Stenzler
    Director
    Alan Torrie
    Director
EDGAR: Offering Information
  • Accession Date:
    03/20/2013
  • First Sale Date:
  • Offering Amount:
    $2,449,104
  • Amount Sold:
    $0
  • Amount Remaining:
    $2,449,104
  • Exemptions:
    Rule 506
  • Security Type(s):
    Each warrant is exercisable for one common share at an exercise price of Cdn$0.575 per share until February 28, 2015.
  • Sales Clarification:
    $2,449,104 may be received upon exercise of share purchase warrants issued both inside and outside the U.S. U.S dollar amounts are based on the Bank of Canada noon rate of exchange reported on March 1, 2013, which was Cdn$1.0285=$1.00.
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Cynapsus Therapeutics Inc./s/ Andrew WilliamsAndrew WilliamsChief Operations Officer and Chief Financial Officer2013-03-18